Pre-treatment of lymphoma cells with the protein synthesis inhibitor cycloheximide (CHX) completely blocked bortezomib-induced up regulation of phosphorylated NF-κB and the levels of NF-κB were also reduced (Figure 6A). The gene discussed is NFKB1; the disease is lymphoma.